Site Search US investigators assessed the effect of both the pentavalent (five-strain) RotaTeq vaccine and Rotarix, a monovalent formulation, on the risk intussusception in infants 5 to 37 weeks old.
Jan. 14, 2014 - Center for Infectious Disease Research and Policy